Übersicht
AbbVie Biotech Ventures is the corporate venture capital arm of AbbVie, a global biopharmaceutical company based in the United States. The fund invests in innovative biotechnology companies developing breakthrough therapies and technologies across various therapeutic areas. AbbVie Biotech Ventures supports early to mid-stage companies that align with AbbVie's strategic interests in advancing patient care and scientific innovation.
Über
AbbVie Biotech Ventures
Wichtige Details
Typ
Venture Capital
Standort
United States
Finanzierungsart
Equity
Phase
Seed
Series a
Series b
See incorrect or outdated information?
